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http://www.equityhealthj.com/content/13/1/36RESEARCH Open AccessThe role of private health providers in HIV testing:
analysis of data from 18 countries
Doug Johnson1* and Xi Cheng2Abstract
Introduction: HIV testing and counseling is a critical component of the overall response to the HIV epidemic in
low and middle income countries. To date, little attention has been paid to the role of private for-profit providers in
HIV testing.
Methods: We use data from Demographic and Health Surveys and AIDS Indicators Surveys to explore the extent to
which this sector provides HIV testing in 18 developing countries.
Results: We find that use of the private sector for HIV testing varies significantly by country, with private for-profit
providers playing a significant role in some countries and a relatively minor one in others. At the country level, use
of private providers for HIV testing is correlated with use of private providers for other health services yet, in many
countries, significant differences between use of the private sector for HIV testing and other services exist. Within
countries, we find that wealth is strongly associated with use of the private sector for HIV testing in most countries,
but the relative socio-economic profile of clients who receive an HIV test from a private provider varies considerably
across countries. On the one measure of quality to which we have access, reported adherence to antenatal care
testing guidelines, there are no statistically significant differences in performance between public and private for-profit
providers in most countries after controlling for wealth.
Conclusions: These results suggest that strategies for supervising and engaging private health providers with regard
to HIV testing should be country specific and take into account local context.
Keywords: HTC, HIV/AIDS, Private health sectorIntroduction
HIV testing and counseling (HTC) is a critical component
of the overall response to the HIV pandemic in developing
countries. While numerous studies have examined the
role of public health providers in providing HIV counsel-
ing and testing, there is a paucity of data on the role
played by private providers in HIV testing in developing
countries [1-3]. In most developing countries, supervision
of private providers is weak and reporting by private pro-
viders to public agencies limited and inconsistent. Thus,
even basic descriptive statistics on the extent of use of pri-
vate providers for HIV testing are rarely included in na-
tional health statistics [4].
Better understanding the role of the private sector in
HTC is important for two reasons. First, in many* Correspondence: douglas_johnson@abtassoc.com
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article, unless otherwise stated.developing countries, a large share of the population,
even the poor, access health care from the private sector
[5]. Given the high use of the private sector for health
care in many countries, governments should ensure that
private health providers are offering HIV tests in cases
where testing is indicated (or referring patients to an-
other facility where testing may be conducted), adhering
to national HTC guidelines, and referring HIV-positive
patients to prevention, care and treatment services. Sec-
ond, relying solely on HTC statistics from the public
sector may lead to under-reporting of national testing
rates, particularly among groups with high utilization of
private providers for testing.
In this paper, we analyze the role played by private
commercial health providers in providing HIV testing in
18 countries. This analysis builds on previous analysis by
Wang et al. [5] which looked at use of the private sector
for HIV testing in 12 countries and analyzed theCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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for testing. Our research extends this analysis by using
several newly available datasets and exploring additional
lines of investigation. We estimate the overall proportion
of those tested for HIV who received their test from a
private provider in each of these countries, compare use
of the private sector for HIV testing with use of the pri-
vate sector for other health services, and investigate the
relationship between household wealth and use of the
private sector for HIV testing.
In addition, we compare public and private providers
on the one measure of quality for which we have data:
adherence to HIV testing protocols during antenatal care
(ANC) visits. According to the World Health Organiza-
tion’s (WHO) provider-initiated testing and counseling
guidelines, all women receiving ANC should be offered
an HIV test even in countries with concentrated and
low-level HIV epidemics [6]. In all countries for which
analysis was performed, with the possible exception of
Benin, Guyana, Haiti, and Malawi, official national
guidelines echo this recommendation that all women re-
ceiving ANC be offered an HIV testa. (In the cases of
Benin, Guyana, Haiti, and Malawi, we were unable to de-
termine the official policy regarding HTC during ANC).
Methods
Country selection
This report uses data from the Demographic and Health
Surveys (DHS) and the AIDS Indictors Surveys (AIS)
conducted by the USAID-funded Measure DHS project.
DHS and AIS are large, nationally- representative,
household surveys focused on maternal and child health
in general (in the case of DHS) and HIV/AIDS in par-
ticular (in the case of AIS)b. The questionnaires, sam-
pling strategies, and other methods used in the DHS and
AIS surveys are very similar across countries. Further,
questions included in AIS are largely a subset of ques-
tions included in the DHS and thus data from the two
sets of surveys are comparable.
The DHS and AIS began including questions on the
source of HIV testing in 2004, and surveys with such
questions have been conducted in 21 countries since
then. Three countries have been excluded from this ana-
lysis as too few respondents had received an HIV test
(Guinea 2005 and Chad 2004) or the non-response rate
to the question regarding source of HIV testing was too
high (Rwanda 2005). In the remaining 18 countries, we
used the latest dataset available if more than one dataset
included data on source of HIV test. Out of the 18 coun-
tries for which we have data, 13 are in Sub-Saharan
Africa (Benin, Cote D'Ivoire, Ethiopia, Kenya, Lesotho,
Liberia, Malawi, Mozambique, Sierra Leone, Swaziland,
Tanzania, Uganda, and Zimbabwe), two are in Southeast
Asia (Cambodia and Vietnam), and three are in theCaribbean region (Dominican Republic, Guyana, and
Haiti). With the exception of the Dominican Republic,
Cambodia, and Vietnam, all countries have HIV preva-
lence rates over 1%. Sample size and other key statistics
for each country included in this analysis are provided in
Table 1.
Variables
Our analysis focuses on the use of private for-profit pro-
viders (hereafter referred to as private providers) for
HIV testing. We define “private providers” as providers
who are not government employees and who seek to
earn a profit. A challenge faced in performing this ana-
lysis was identifying which types of providers are private
and which are not. Answer choices for the question re-
garding source of most recent HIV test included both
government and non-government facilities but did not
explicitly distinguish between private commercial pro-
viders and other non-governmental providers. In addition,
the response options to this question vary across coun-
tries, with specific local options included. In most cases,
determining whether an answer option referred to a pri-
vate commercial provider was straightforward. However,
in cases where it was unclear, we relied on local experts
for guidance in coding the source of HIV testc. Non-
response rates for the question regarding provider type for
most recent HIV test are below 5% for all datasets except
for the Malawi men’s dataset in which the non-response
rate was 8.5%.
We utilize the wealth quintile variable included in the
DHS and AIS datasets to analyze testing by socio-
economic status. As DHS and AIS surveys do not in-
clude questions on consumption expenditure, the wealth
index is calculated using information on asset ownership
and housing characteristics. Wealth rankings based on
this index have been shown to be broadly consistent
with wealth rankings based on consumption expenditure
aggregates [7]d.
In the second section of this paper, we compare use of
the private sector for HIV testing with use of the private
sector for other health services by country. DHS datasets
include data on source of care for five additional health
services: STI treatment, family planning, child fever/
cough, ANC, and child diarrhea. AIS datasets do not in-
clude this data and countries for which we rely on AIS
datasets are excluded from this analysis.
The DHS and AIS datasets do not provide information
on the overall quality of HIV testing and counseling pro-
vided by public and private practitioners but do provide
information on whether HIV testing was provided dur-
ing ANC. In particular, for women who gave birth in the
five years prior to the survey and received antenatal care,
DHS and AIS surveys ask whether the respondent was
offered an HIV test, whether she received an HIV test,















Benin 2006 DHS 602 1.2% 17,794 3,055 5,321 676
Cambodia 2010 DHS 795 0.5% 18,754 4,695 8,239 1,986
Cote D'Ivoire 2005 AIS 908 4.8% 5,183 397 4,503 295
DR 2007 DHS 4,334 0.8% 27,195 18,104 27,975 11,651
Ethiopia 2011 DHS 358 1.5% 16,515 6,915 14,110 5,991
Guyana 2008 DHS 2,558 1.2% 4,996 2,525 3,522 1,272
Haiti 2006 DHS 515 2.1% 10,757 1,918 4,958 508
Kenya 2008 DHS 794 6.3% 8,444 4,915 3,465 1,437
Lesotho 2008 DHS 764 23.6% 7,624 5,193 3,317 1,321
Liberia 2007 DHS 211 1.8% 7,092 287 6,009 346
Malawi 2010 DHS 339 11.0% 23,020 17,046 7,175 3,845
Mozambique 2009 AIS 428 11.5% 6,413 2,596 4,799 1,073
Sierra Leone 2008 DHS 348 1.6% 7,374 1,006 3,280 278
Swaziland 2006 DHS 2,894 25.7% 4,987 2,040 4,156 804
Tanzania 2010 DHS 524 5.6% 10,139 5,732 2,527 1,055
Uganda 2011 DHS 487 6.5% 8,674 6,505 2,295 1,282
Vietnam 2006 AIS 731 0.4% 7,289 585 6,707 603
Zimbabwe 2011 DHS 776 14.3% 8,948 5,499 7,480 2,810
Notes: All data on GDP per capita and HIV prevalence from World Bank data catalogue (accessed from http://data.worldbank.org) except for data on HIV prevalence in
Ethiopia which was obtained from 2012 UNAIDS Ethiopia country progress report (access from http://www.unaids.org/en/dataanalysis/knowyourresponse/
countryprogressreports/2012countries/GAP%20Report%202012.pdf).
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information was combined with information on the type
of provider delivering the ANC to determine the propor-
tion of public and private providers who offer HIV test-
ing during ANC.
All analysis was performed using Stata 12.
Statistical analysis
The majority of the results presented in this paper were
compiled through basic tabulations and cross tabula-
tions. Where appropriate, we have included confidence
intervals (at the 95% level) of estimates and significance
levels for comparisons of means based on t-tests.
In our comparison of use of the private sector for HIV
testing with use of the private sector for other health
services, we calculate correlation coefficients between
overall utilization of the private sector for HIV testing
and overall utilization of the private sector for other health
services at the country level. (As the subset of respondents
utilizing each service varies considerably we are unable to
calculate the correlation at the individual level).
To compare adherence of public and private providers
to ANC HIV testing guidelines, we employ a linear
probability model to estimate the difference between
public and private providers in the probability of offering
of an HIV test after controlling for respondent wealth.
Limiting the sample to women who were pregnant inthe last five years and received ANC from either a public
or private provider, the dependent variable is a binary
variable for whether the respondent was offered an HIV
test during ANC and our explanatory variables are a bin-
ary variable for whether the provider was from the pri-
vate sector and binary variables for wealth quintiles. Use
of a linear probability model facilitates easy interpret-
ation of our results: the coefficient on the binary variable
indicating use of a private provider is the expected in-
crease in the probability of being offered an HIV test as-
sociated with receiving ANC from a private provider as
opposed to a public providere.
Results
Use of private for-profit providers for HIV testing by country
Use of the private sector for HIV testing varies signifi-
cantly by country with private providers playing a sub-
stantial role in some countries and a relatively minor
one in others. Figure 1 displays the overall proportion of
men and women who have ever received an HIV test by
country. Figure 2 presents the proportion of men and
women who were tested for HIV who received this test
from a private provider. In Mozambique, only 1% of
women who were tested for HIV received that test from
a private provider, while in Haiti the comparable figure
was 43%. Across countries, average utilization of the pri-
vate sector for HIV testing was 15.6%.
Figure 1 Proportion of adults who have ever received an HIV test. Note: Stars indicate statistical significance of t test of difference between
men and women at the 10% (*), 5% (**), and 1% (***) levels.
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relative use of the private sector for HIV testing is higher
among men than women in most countries. In 10 out of 18
countries, the difference between men and women’s
utilization of the private sector for HIV testing was positive
and statistically significant at the 5% level or higher. In only
two countries, Benin and Tanzania, was this difference
negative and statistically significant at the 5% level. In some
countries, this difference is substantial. In Kenya for ex-
ample, men who were tested for HIV were 16 percentage
points more likely to have received that test from a private
provider than women. These differences are partially, but
not fully, explained by HIV testing at ANC. As the subse-
quent analysis shows, in most countries women are more
likely to have received their most recent ANC care at a
public facility than to have received their most recent HIV
test from a public provider. Since testing during ANC ac-
counts for a significant portion of total HIV testing among
women, testing during ANC drives the overall figure forFigure 2 Proportion of those tested for HIV who received test from p
difference between men and women at the 10% (*), 5% (**), and 1% (***)utilization of the private sector for HIV testing downf. Yet
even after excluding women who received their most recent
HIV test as part of ANC, men are still more likely to have
been tested by a private provider than women. For those
countries for which we have data on whether the most re-
cent HIV test was during ANC, the average of the country-
level differences between men and women including all
women is 4.2 percentage points. If we exclude women who
received their most recent HIV test during ANC, the aver-
age of the differences is 3.4 percentage points.
The relatively limited number of countries for which
we have data prevents us from determining which
country-level variables are most associated with high use
of the private sector for HIV testing.
Use of private providers for HIV testing compared to use
of private providers for other health services by country
Comparing use of the private sector for HIV testing with
use of the private sector for other health services mayrivate provider. Note: Stars indicate statistical significance of t test of
levels.
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private sector for HIV testing. If use of the private sector
for HIV testing is highly correlated with use of the private
sector for other services, then use of the private sector for
testing is likely determined largely by the overall size of
the private sector in a given country. On the other hand, if
no such correlation exists, we must look elsewhere to ex-
plain rates of private sector utilization for HIV testing.
Figure 3 displays overall use of the private sector for a
variety of basic health services, including HIV testing, by
country. Across the countries for which we have data,
utilization of the private sector for HIV testing exhibits
the strongest correlation with utilization of the private
sector for ANC (correlation coefficient of .88, p-value of
0.0001). The correlation between utilization of the pri-
vate sector for HIV and utilization of the private sector
for family planning and STI treatment is also strong and
statistically significant (correlation coefficients of .77 and
.69 and p-values of .0014 and .0064 respectively). The
correlation with utilization of the private sector for
fever/cough and diarrhea is not statistically significant.
Despite high overall country level correlation between
use of the private sector for HIV testing and other health
services, significant differences between use of the private
sector for these services exist. For example, in the East
African countries of Uganda, Ethiopia, and Tanzania and
in Cambodia, the private sector was used for HIV testing
much less than for most other health services.
Household wealth and use of the private sector for HIV
testing
Household wealth is strongly associated with being
tested for HIV and, among those tested, use of privateFigure 3 Usage of private sector for various health services among wom
included as data on source of other health services not included in these datproviders for HIV testing in most countries. Figure 4
displays HIV testing rates for women by wealth quintile.
Figure 5 displays the proportion of women who received
their most recent HIV test from a private provider
among those tested. We do not present data on HIV
prevalence rates by wealth quintile here, but note that
other authors have found a positive correlation between
wealth quintile and HIV prevalence in many of these
countries [8]. In all countries but two (the Dominican
Republic and Lesotho), the difference in HIV testing
rates between women in the top two quintiles and other
women is positive and statistically significant at the 1%
level. Similarly, in all countries but four (Cote D’Ivoire,
Haiti, Liberia, and Uganda), the difference in utilization
of the private sector for HIV testing between women in
the top two quintiles and other women is positive and
statistically significant at the 1% level.
As the wealthy are both more likely to be tested for
HIV and, among those who are tested, more likely to be
tested by a private provider, a large share of those tested
by private providers in several countries come from the
top wealth quintiles. Figure 6 presents the proportion of
women from each quintile among those tested for HIV
by a private provider. In 10 out of 18 countries, over half
of women tested for HIV by a private provider are from
the top wealth quintile.
The figure also shows that there is wide variation in
the socio-economic profile of those tested by private
providers for HIV across countries. Despite higher HIV
testing rates and utilization of private providers for HIV
testing among the wealthy, in several countries a sub-
stantial portion of those tested by private providers are
from the lower wealth quintiles. In five of the countries,en. Note: Cote D’Ivoire, Mozambique, Vietnam, and Swaziland not
asets. Data on provider type for ANC missing for Benin and Tanzania.
Figure 4 Proportion of women tested for HIV by wealth quintile.
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were from one of the bottom 3 wealth quintiles.
Comparing adherence of public and private providers to
ANC HIV testing guidelines
Figure 7 shows the proportion of women who reported
that they were offered an HIV test during ANC disaggre-
gated by provider typeg. In 5 out of 12 countries for
which there are data, the difference between the propor-
tion of women who were offered an HIV test during an
ANC visit at a private provider and the proportion of
women who were offered an HIV test during an ANC
visit to a public provider is positive and statistically sig-
nificant at the 5% level. In only one country, Uganda,
was this difference negative and statistically significant at
the 5% level.
This overall comparison of public vs. private providers
ignores important potential differences in the types of
patients who visit public and private providers for ANC.
For example, patients who receive ANC care from pri-
vate providers may be wealthier on average and thus
more likely to demand, and be able to afford, an HIV
test. We attempt to isolate the effect of provider type on
the likelihood of being offered an HIV test during ANC by
performing linear regressions, for each country, of
whether the respondent was offered an HIV test on a bin-
ary variable indicating whether the provider was from the
private sector and binary variables for wealth quintiles.Figure 5 Proportion of women tested who received test from privateTable 2 presents results from these regressions. After con-
trolling for wealth, the difference in reported rates of being
offered an HIV test during ANC between private and pub-
lic providers is still positive and statistically significant at
the 5% level or higher in 3 countries – the Dominican Re-
public, Sierra Leone, and Zimbabwe – but is negative and
statistically significant at the 10% level in 2 countries –
Malawi and Uganda.
Discussion
Using data from 18 countries, we analyzed overall pat-
terns in use of the private sector for HIV testing. Our re-
sults expand and update the results from Wang et al. [5]
who analyzed use of the private sector for HIV testing
for a smaller set of countries and performed a more lim-
ited range of analyses. Our analysis shows that use of the
private sector for HIV testing varies substantially across
countries, with private providers playing a prominent
role in some countries and a relatively minor one in
others. For example, in Haiti 43% of women tested for
HIV received their most recent test from a private pro-
vider, while in Mozambique the comparable figure was
only 1%. Similarly, we find that while in most countries
wealthier women are both more likely to be tested for
HIV and more likely to use a private provider if they are
tested, the socio-economic profile of women tested for
HIV by private providers also varies considerably across
countries. This result contrasts with other recent studies,provider by wealth quintile.
Figure 6 Proportion of women from each wealth quintile among those tested for HIV by a private provider.
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treatment for child diarrhea in sub-Saharan Africa,
found relatively little variation in utilization of private
providers by wealth quintile.
These results suggest that strategies for supervising
and engaging private health providers should be country
specific and take into account local context. A strategy
for engaging private providers appropriate for countries
with very low private sector utilization for HIV testing
and in which users of private providers for HIV testing
are predominantly better off, such as Mozambique orFigure 7 Proportion of women who received ANC who were offered HI
Tanzania, and Vietnam excluded due to lack of data.Vietnam, may not be suitable for countries with high
utilization and more equitable use of private providers for
HIV testing such as Haiti, Liberia, and the Dominican
Republic.
In the set of analyses, we show that, at the country
level, utilization of the private sector for HIV testing is
strongly correlated with utilization of the private sector
for ANC, STI treatment, and family planning but not
particularly correlated with utilization of the private sec-
tor for treatment of childhood illness such as fever and
diarrhea. This relationship may reflect differences in theV test by provider type. Note: Benin, Cote D’Ivoire, Liberia, Swaziland,
Table 2 Combined results from regressions of whether
respondent was offered HIV test during ANC on provider
type and wealth quintile






Cambodia 5.62 (7.37) 3498
DR 1.24** (0.57) 5863
Ethiopia −7.59 (5.77) 2151
Guyana −2.06 (2.82) 1030
Haiti 2.48 (2.72) 2214
Kenya −2.86 (3.36) 3014
Lesotho 1.04 (2.94) 1438
Malawi −6.48* (3.35) 9720
Mozambique 7.05 (10.71) 1967
Sierra Leone 14.07*** (3.98) 1971
Uganda −10.31*** (2.83) 3458
Zimbabwe 4.19** (1.90) 2638
Notes: Stars indicate statistical significance of the coefficient at the 10% (*),
5% (**), and 1% (***) levels.
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issues versus those of their children. Alternatively, it
may reflect differences in the provider skills and infra-
structure required to perform HIV tests compared to
these other services.
Closer inspection of utilization of the private sector
for these health services by country reveals that while
there is strong overall correlation across countries in
utilization, in several countries use of the private sector
for HIV testing lags behind use of the private sector for
other health services. In particular, in the East African
countries of Uganda, Ethiopia, and Tanzania and in
Cambodia, the private sector was used for HIV testing
far less than for most other health services. Differences
in private sector utilization may be due to differences in
levels of public and donor funding for HIV testing ver-
sus other health services or a variety of other factors.
The limited number of countries for which we have data
prevents us from determining whether these differences
are correlated with country level variables. Further re-
search at the country level to determine reasons for
these differences is warranted.
We find that men use private providers for HIV test-
ing at significantly higher rates than women in several
countries. HIV testing during ANC visits helps explain a
portion of this difference. Yet even after accounting for
HIV testing during ANC in the countries for which we
have data, men are still more likely to use a private pro-
vider for HIV testing.
An important concern for policymakers charged with
oversight of the health sector is whether the private sec-
tor delivers care at the same level of quality as the publicsector. Some researchers and policymakers have ques-
tioned whether the quality of care delivered by private
health providers is as good as that delivered by public
providers. For example, in a meta-review of research
comparing quality of public and private health providers,
Basu et al. [9] show that several of the studies they
reviewed found that quality of service provision by pri-
vate providers was lower than that of public providers.
We compare public and private on the one measure of
quality to which we have access – reported adherence to
international ANC testing protocols. While HIV testing
during ANC captures only a small part of overall quality
of HIV testing, it is a particularly useful metric with
which to compare public and private providers. Accord-
ing to the WHO, HIV testing should always be per-
formed during ANC regardless of circumstances [6].
Further, DHS data reveals that testing during ANC ac-
counts for a large share of total HIV testing among
women in many countries. Without controlling for
wealth, we find that reported adherence to HIV testing
protocol is higher for private providers than public facil-
ities in 5 countries and worse in 2. Controlling for
wealth, the disparity in performance between public and
private providers on ANC testing across countries, for
the most part, disappears.
Our analysis suffers from several limitations. In most
cases, distinguishing between private for profit providers
and other types of providers based on the answer op-
tions included in the DHS questionnaires was straight-
forward. Yet in a small number of cases we were unsure
whether an answer option referred to a private for profit
provider, a private not-for-profit provider or to both
types. In the second half of this paper, we compare pub-
lic and private providers on adherence to ANC testing
guidelines. While useful, this relatively crude comparison
should not be interpreted as an overall comparison of
the quality of HIV testing by public and private pro-
viders which we are unable to perform due to a lack of
data on quality. Data on the relative quality of public
and private providers, collected perhaps through mystery
clients or vignette surveys, would have greatly strength-
ened our analysis. Lastly, we are unable to draw any con-
clusions as to why respondents chose one type of
provider over another. Data on the availability of public
and private facilities, which was included in previous
versions of DHS surveys but subsequently dropped,
would have allowed us to investigate what affect distance
to different facility types had on use.
HIV counseling and testing is a critical part of the
overall response to the pandemic. In this paper, we
examine the role of the private sector in HIV testing.
We show that the private sector, despite the relatively lit-
tle attention it receives, plays a significant role in deliv-
ering HIV testing in several countries. Further research
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regards to HIV testing conducted by private providers
may shed additional light on how private providers can
be further leveraged to increase HIV testing rates, and
ensure a more accurate accounting of the epidemic
through improved reporting of positive test cases.
Endnotes
aFor Cambodia, see http://www.who.int/hiv/pub/guide-
lines/cambodia_art.pdf?ua=1; for Cote D’Ivoire see http://
www.pepfar.gov/pepfar/press/84152.htm; for Dominican
Republic see http://www.who.int/hiv/pub/guidelines/
dominican_art.pdf; for Ethiopia see http://www.who.int/




pdf; for Liberia see http://apps.who.int/medicinedocs/
documents/s18366en/s18366en.pdf; for Mozambique see
http://www.unicef.org/infobycountry/mozambique_58831.
html; for Sierra Leone see http://www.whosierraleone.
org/1_docs/mohspartnersdocs/sl_operational_plan.pdf;
for Swaziland see http://www.who.int/hiv/pub/guidelines/
swaziland_art.pdf; for Tanzania see http://www.who.int/
hiv/pub/guidelines/tanzania_art.pdf and http://ihi.eprints.
org/823/1/MoHSW.pdf_(53).pdf; for Uganda see http://
www.who.int/hiv/pub/guidelines/uganda_art.pdf; for
Vietnam see http://www.unicef.org/vietnam/MIV_Eng.
pdf; for Zimbabwe see http://www.safaids.net/content/
zimbabwe-national-hiv-and-aids-strategic-plan-znasp-
ii-2011-%E2%80%93-2015
bFurther details on the sampling strategy and method-




cDetails of how we coded each answer option available
from the authors on request.
dFor more information on how wealth quintiles are
calculated for DHS and AIS surveys see Rutstein and
Johnson [10].
eLinear probability models have been criticized on the
basis that they do not provide consistent estimates of
the marginal effects if the true data generating process is
non-linear, as it often is in the case of binary dependent
variables. While valid, this criticism is equally applicable
to non-linear models which do not accurately capture
the true non-linear data generating process. Further, our
model is nearly fully saturated (in the sense that our
model includes separate parameters for almost all pos-
sible values of the explanatory variables) and thus
unlikely to suffer from serious non-linearities. As a spe-
cification check, we count the number of predicted
values from our model which fall outside the unitinterval [11]. For all countries except the Dominican Re-
public all predicted values from our model fall within
the unit interval. In the case of the Dominican Republic,
less than 10% of the predicted values fall outside the unit
interval.
fThe proportion of women tested from HIV who re-
ceived their most recent HIV test as part of ANC varies
from 10.8% in Ethiopia to 47.6% in Benin. Data on propor-
tion of women tested for HIV who received most recent
test during ANC not available for Liberia, Swaziland,
Tanzania, Mozambique, Vietnam, and Cote D’Ivoire.
gResults for Benin, Cote D’Ivoire, Liberia, Swaziland,
Tanzania, and Vietnam excluded as these datasets do
not include information on source of ANC care.
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